CICCONE, VALERIO
 Distribuzione geografica
Continente #
EU - Europa 1.095
NA - Nord America 999
AS - Asia 164
AF - Africa 1
SA - Sud America 1
Totale 2.260
Nazione #
US - Stati Uniti d'America 998
IE - Irlanda 283
IT - Italia 247
GB - Regno Unito 235
SE - Svezia 129
CN - Cina 58
VN - Vietnam 58
FR - Francia 52
DE - Germania 34
UA - Ucraina 34
FI - Finlandia 25
ES - Italia 23
SG - Singapore 23
RU - Federazione Russa 13
IN - India 12
BE - Belgio 8
TR - Turchia 7
HK - Hong Kong 4
AT - Austria 3
NL - Olanda 2
AZ - Azerbaigian 1
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
ZA - Sudafrica 1
Totale 2.260
Città #
Dublin 279
Southend 217
Fairfield 144
Chandler 138
Ashburn 109
Siena 78
Woodbridge 70
Wilmington 59
Dong Ket 57
Ann Arbor 55
Seattle 53
Cambridge 48
Houston 44
Florence 37
Princeton 33
Jacksonville 31
Helsinki 23
Málaga 23
Beijing 17
Fremont 14
Singapore 13
Rome 11
Dearborn 10
Moscow 9
Pune 9
San Mateo 9
Brussels 8
London 8
Nanjing 8
Prato 8
San Diego 8
Boardman 7
Izmir 5
San Francisco 5
Avezzano 4
Cagliari 4
Jinan 4
New York 4
Norwalk 4
Shenyang 4
Tianjin 4
Falls Church 3
Fiesole 3
Pisa 3
Vienna 3
Amsterdam 2
Changsha 2
Como 2
Curinga 2
Fucecchio 2
Gunzenhausen 2
Haikou 2
Hebei 2
Milan 2
Nanchang 2
Naples 2
Ningbo 2
Peccioli 2
Phoenix 2
Recanati 2
Saint-Fons 2
Shanghai 2
Tukwila 2
Varese 2
Acton 1
Albuquerque 1
Athens 1
Atlanta 1
Baku 1
Bergamo 1
Bishkek 1
Bonndorf 1
Boston 1
Budapest 1
Böblingen 1
Caserta 1
Castelfranci 1
Central 1
Centurion 1
Chicago 1
Frankfurt am Main 1
Guangzhou 1
Hounslow 1
Indore 1
Kilburn 1
Kocaeli 1
Landriano 1
Lima 1
Los Angeles 1
Maddaloni 1
Modena 1
Monteroni d'Arbia 1
Napoli 1
New Bedfont 1
Nola 1
Palermo 1
Pavia 1
Prague 1
Redmond 1
Redwood City 1
Totale 1.761
Nome #
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 183
The metal-nonoate Ni(SalPipNONO) inhibits in vitro tumor growth, invasiveness and angiogenesis 155
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 154
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 146
Efficacy of AdipoDren ® in Reducing Interleukin-1-Induced Lymphatic Endothelial Hyperpermeability 136
Anti-hypertensive property of a nickel-piperazine/NO donor in spontaneously hypertensive rats 128
Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: in vivo and ex vivo analysis 127
Comparison of the Effect of Two Hyaluronic Acid Preparations on Fibroblast and Endothelial Cell Functions Related to Angiogenesis 119
By-products from winemaking and olive mill value chains for the enrichment of refined olive oil: Technological challenges and nutraceutical features 106
Endothelium as therapeutic target in breast and lung cancer progression: the role of nitric oxide and stemness marker ALDH1A1 102
Molecular mechanisms of resistance to anti-angiogenic drugs 91
Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness 82
Characterization of the Safety Profile of Sweet Chestnut Wood Distillate Employed in Agriculture 82
Studying Angiogenesis in the Rabbit Corneal Pocket Assay 81
Effect of nir laser therapy by mls‐mis source on fibroblast activation by inflammatory cytokines in relation to wound healing 79
Development of fortified citrus olive oils: From their production to their nutraceutical properties on the cardiovascular system 72
Endothelium as a source and target of H2S to improve its trophism and function 65
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 62
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 60
The H2S-donor erucin exhibits protective effects against vascular inflammation in human endothelial and smooth muscle cells 53
State-of-the-Art in Antiangiogenic Agents in Cancer Therapy 45
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 43
Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? 41
Optimization of an Ex-Vivo Human Skin/Vein Model for Long-Term Wound Healing Studies: Ground Preparatory Activities for the 'Suture in Space' Experiment Onboard the International Space Station 40
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 36
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis 30
The Nitric Oxide Donor [Zn(PipNONO)Cl] Exhibits Antitumor Activity through Inhibition of Epithelial and Endothelial Mesenchymal Transitions 23
Cornerstones of CT urography: a shared document by the Italian board of urogenital radiology 21
Erucin, a natural isothiocyanate, exerts pro-angiogenic properties in cultured endothelial cells and reverts angiogenic impairment induced by high glucose 9
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling 6
Totale 2.377
Categoria #
all - tutte 10.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020355 39 10 12 31 27 32 37 46 39 33 26 23
2020/2021481 18 28 11 34 53 53 10 51 39 69 27 88
2021/2022405 26 32 31 43 52 21 14 24 16 24 51 71
2022/2023523 28 64 57 55 42 117 23 38 51 27 15 6
2023/2024450 13 10 44 38 17 120 155 11 5 7 8 22
2024/202540 40 0 0 0 0 0 0 0 0 0 0 0
Totale 2.377